NCT00515788 - DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Neoplastic Meningitis

Interventions

DRUG

DepoCyt

Starting dose of 50 mg Intrathecal on Day 1 every 14 days for a total of 12 weeks (6 treatments). After the first 12 weeks, 50 mg Intrathecal on Day 1 every 28 days for 40 weeks (10 treatments).

DRUG

Temozolomide

100 mg/m\^2 (capsules) by mouth daily for 7 consecutive days every 14 days.

Trial Locations (1)

77030

U.T.M.D. Anderson Cancer Center, Houston